Successful Management of Suspected Epstein–Barr Virus‐Associated Hemophagocytic Lymphohistiocytosis in BRAF ‐Mutant Cholangiocarcinoma Following Treatment With Immune Checkpoint Inhibitors and BRAF / MEK Inhibitors: A Case Report

Documenti analoghi

• Efficacy and safety of endoscopic ultrasound‐guided gallbladder drainage without dilation by using a 0.035‐inch stiff guidewire
  di: Michihiro Ono, et al.
  Pubblicazione: (2024)
• MEK Pathway Inhibitor‐Mediated Response in BRAF V600‐Mutant Melanoma with Brain Parenchymal and Leptomeningeal Metastases
  di: Saud Alhusaini, et al.
  Pubblicazione: (2024)
• C‐Terminal Hsp90 Inhibitors Overcome MEK and BRAF Inhibitor Resistance in Melanoma
  di: Chitra Subramanian, et al.
  Pubblicazione: (2025)
• Brugada Phenocopy Induced by BRAF and MEK Inhibitors in a Lung Adenocarcinoma
  di: Leonardo Portolan, et al.
  Pubblicazione: (2024)
• Cardiotoxicity of BRAF/MEK inhibitors
  di: Katharina Seuthe, et al.
  Pubblicazione: (2026)